Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Skolnik

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Public Health|December 30, 2004
Effective HIV case identification through routine HIV screening at urgent care centers in MassachusettsRochelle P Walensky, Elena Losina, Laureen Malatesta, et al.
AIDS Care|June 8, 2013
Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherenceAmy S Baranoski, Elizabeth Meuser, Helene Hardy, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
AIDS Patient Care and Stds|February 12, 2011
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfectionShikha Garg, Melanie Hoenig, Erika M Edwards, et al.
Substance Abuse|December 2, 2008
Predictors of treatment for hepatitis C virus (HCV) infection in drug usersCarrie Reed, Sherri O Stuver, Sheila Tumilty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
The Journal of Infectious Diseases|October 31, 2009
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211Zhaohui Su, Roy M Gulick, Amy Krambrink, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 2010
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patientsTimothy J Wilkin, Zhaohui Su, Amy Krambrink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Highly active antiretroviral therapy and viral response in HIV type 2 infectionChristopher Mullins, Geoffrey Eisen, Stephen Popper, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Public Health|December 30, 2004
Effective HIV case identification through routine HIV screening at urgent care centers in MassachusettsRochelle P Walensky, Elena Losina, Laureen Malatesta, et al.
AIDS Care|June 8, 2013
Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherenceAmy S Baranoski, Elizabeth Meuser, Helene Hardy, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
AIDS Patient Care and Stds|February 12, 2011
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfectionShikha Garg, Melanie Hoenig, Erika M Edwards, et al.
Substance Abuse|December 2, 2008
Predictors of treatment for hepatitis C virus (HCV) infection in drug usersCarrie Reed, Sherri O Stuver, Sheila Tumilty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
The Journal of Infectious Diseases|October 31, 2009
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211Zhaohui Su, Roy M Gulick, Amy Krambrink, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 2010
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patientsTimothy J Wilkin, Zhaohui Su, Amy Krambrink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Highly active antiretroviral therapy and viral response in HIV type 2 infectionChristopher Mullins, Geoffrey Eisen, Stephen Popper, et al.
Pageof 4